📰 Expanded Access Program News
Page 15 - Expanded Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access Program. Real-time updates on events, politics, business and more.
July 28, 2022
VolitionRx Limited announced that it has commenced an underwritten public offering of common stock. The size and scope of the offering will depend on market...
July 21, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
July 12, 2022
Talicia® - World Gastro 2022 congress (August 17-18): RedHill invited to give prestigious oral presentation of important data detailing high eradication rates...
July 10, 2022
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into...
July 10, 2022
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into...
July 10, 2022
MELBOURNE, Australia, July 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed...
June 24, 2022
Six-year natural history comparison with maralixibat demonstrates event-free and transplant-free survival in patients with Alagille syndrome Maralixibat data highlighting predictors of event-free
June 17, 2022
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will report...
June 4, 2022
Overall Response Rate (ORR) of 60% Observed in Patients with Relapsed or Refractory (R/R) EBV+ PTLD Consistent with Previously Reported StudiesCompletion of All Pre-Approval Inspections Required to Support EU Marketing Authorization Application; Anticipated European Commission Approval On-Track for Q4 2022SOUTH SAN...
May 26, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced positive results from the...